| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Valproate Impurity 47 |
丙戊酸雜質(zhì)47 |
6065-63-0 |
詳細(xì)
|
| Cabotegravir |
卡博特韋 |
1051375-10-0 |
詳細(xì)
|
| Licoricesaponin A3 |
Licoricesaponin A3 |
118325-22-7 |
詳細(xì)
|
| 6-Methylnicotinonitrile |
6-甲基煙腈 |
3222-48-8 |
詳細(xì)
|
| Sitagliptin Impurity 124 |
西他列汀雜質(zhì)124 |
1151240-88-8 |
詳細(xì)
|
| Diethyl 2-(4-chlorobenzamido)-2-((2-oxo-1,2-dihydroquinolin-4-yl)methyl)malonate |
|
1028268-32-7 |
詳細(xì)
|
| Acrylic Acid Impurity 3 |
丙烯酸雜質(zhì)3 |
65967-52-4 |
詳細(xì)
|
| 2-Naphthyl isocyanate |
2-萘基異氰 |
10124-78-4 |
詳細(xì)
|
| Bisacodyl Impurity 9 |
比沙可啶雜質(zhì)9 |
53555-73-0 |
詳細(xì)
|
| Ketorolac Impurity 55 |
酮咯酸雜質(zhì)55 |
|
詳細(xì)
|
| 2,6-Dichloroterephthalic acid |
2,6-二氯對苯二甲酸 |
116802-97-2 |
詳細(xì)
|
| Olopatadine Impurity 13 |
奧洛他定雜質(zhì)13 |
113835-76-0 |
詳細(xì)
|
| ilexsaponin B2 |
毛冬青皂苷B2 |
108906-69-0 |
詳細(xì)
|
| Vortioxetine Impurity 51 |
沃替西汀雜質(zhì)51 |
1610527-49-5 |
詳細(xì)
|
| Hex-3-en-1-yl 3-methylbutanoate |
|
10032-11-8 |
詳細(xì)
|
| Pomalidomide Impurity 3 |
泊馬度胺雜質(zhì)3 |
2635-64-5 |
詳細(xì)
|
| N-phenylpropionamide |
N-苯基丙酰胺 |
620-71-3 |
詳細(xì)
|
| Levomedetomidine N3-β-D-GlucuronideDISCONTINUED |
|
1061620-92-5 |
詳細(xì)
|
| P-hydroxyphenyl Glyoxal monohydrate |
對羥苯基乙二醛合一水 |
24645-80-5 |
詳細(xì)
|
| Hydroxychloroquine Impurity 47 |
羥氯喹雜質(zhì)47 |
|
詳細(xì)
|
| Carteolol Impurity 28 |
卡替洛爾雜質(zhì)28 |
823-19-8 |
詳細(xì)
|
| Ethyl Trifluoromethanesulfonate |
三氟甲基磺酸乙酯 |
425-75-2 |
詳細(xì)
|
| Pazufloxacin Impurity 17 |
帕珠沙星雜質(zhì)17 |
164851-44-9 |
詳細(xì)
|
| Tenofovir dipivuroxime enrutabine adduct |
替諾福韋二吡呋酯恩曲他濱加合物 |
1962114-98-2 |
詳細(xì)
|
| Tenofovir monopyrfuroxil enrutabine adduct |
替諾福韋單吡呋酯恩曲他濱加合物 |
|
詳細(xì)
|
| 4-Chloro-7-nitrobenzo-2-oxa-1,3-oxadiazole |
4-氯-7-硝基苯并-2-氧雜-1,3-二唑 |
10199-89-0 |
詳細(xì)
|
| Dronedarone Impurity 29 |
決奈達(dá)隆雜質(zhì)29 |
|
詳細(xì)
|
| Pazufloxacin Impurity 20 |
帕珠沙星雜質(zhì)20 |
165071-03-4 |
詳細(xì)
|
| Oxiracetam impurity 22 |
奧拉西坦雜質(zhì)22 |
25747-41-5 |
詳細(xì)
|
| Phytyl Acetate (cis- and trans- mixture) |
Phytyl Acetate (cis- and trans- mixture) |
10236-16-5 |
詳細(xì)
|
| Olopatadine Methyl Ester |
|
113805-71-3 |
詳細(xì)
|
| Methyl (Z)-1-acetyl-3-(ethoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
1175365-43-1 |
詳細(xì)
|
| Ilexoside K |
冬青苷K |
109008-26-6 |
詳細(xì)
|
| Leflunomide impurity 8 |
來氟米特雜質(zhì)8 |
108605-62-5 |
詳細(xì)
|
| Triethyl Methanetricarboxylate |
甲烷三羧酸三乙酯 |
6279-86-3 |
詳細(xì)
|
| Chloroorienticin A |
氯東方菌素A |
118395-73-6 |
詳細(xì)
|
| 3-Hydroxyhexanoic Acid |
3-羥基己酸 |
10191-24-9 |
詳細(xì)
|
| Aripiprazole Impurity 61 |
阿立哌唑雜質(zhì)61 |
63309-35-3 |
詳細(xì)
|
| Ilexhainanoside D |
海南冬青苷D |
1137648-52-2 |
詳細(xì)
|
| Pazufloxacin Impurity 10 |
帕珠沙星雜質(zhì)10 |
165071-09-0 |
詳細(xì)
|
| (2-Vinyl-1,3-dioxane-5,5-diyl)dimethanol |
|
29178-30-1 |
詳細(xì)
|
| 4-(3-Chlorophenyl)piperidine-2,6-dione |
4-（3-氯苯基）哌啶-2,6-二酮 |
113675-65-3 |
詳細(xì)
|
| Terazidone Impurity 1 |
特拉齊酮雜質(zhì)1 |
|
詳細(xì)
|
| Istradefylline Impurity 15 |
伊曲茶堿雜質(zhì)15 |
89073-60-9 |
詳細(xì)
|
| 16a-Methyl Prednisolone |
|
10417-63-7 |
詳細(xì)
|
| 11130-20-4
silicic acid; tetrakis(tungsten oxide) |
|
11130-20-4 |
詳細(xì)
|
| Ruxolitinib Impurity N5 |
魯索利替尼雜質(zhì)N5 |
1153949-38-2 |
詳細(xì)
|
| Catechol-d4 |
1,2-苯二酚-3,4,5,6-D4 |
103963-58-2 |
詳細(xì)
|
| Vortioxetine Impurity 89 |
沃替西汀雜質(zhì)89 |
1019453-85-0 |
詳細(xì)
|
| Istradefylline Impurity 20 |
伊曲茶堿雜質(zhì)20 |
1785764-26-2 |
詳細(xì)
|
| Decitabine Impurity 25 |
地西他濱雜質(zhì)25 |
|
詳細(xì)
|
| Pregabalin Impurity 15 |
普瑞巴林雜質(zhì)15 |
1083246-65-4 |
詳細(xì)
|
| Pazufloxacin Impurity 11 |
帕珠沙星雜質(zhì)11 |
165071-10-3 |
詳細(xì)
|
| Cefaclor Impurity 20 |
頭孢克洛雜質(zhì)20 |
|
詳細(xì)
|
| Indacaterol Impurity 22 |
茚達(dá)特羅雜質(zhì)22 |
2598-30-3 |
詳細(xì)
|
| Risperidone Impurity 25 |
利培酮雜質(zhì)25 |
832747-59-8 |
詳細(xì)
|
| (3R,5R)-Rosuvastatin |
|
1094100-06-7 |
詳細(xì)
|
| Methyl 2-amino-3-bromo-5-chlorobenzoate |
|
101080-36-8 |
詳細(xì)
|
| 6-Hydroxy-4-Methylcoumarin |
6-羥基-4-甲基香豆素 |
2373-31-1 |
詳細(xì)
|
| Tenofovir disoproxil Impurity 108 |
替諾福韋雜質(zhì)108 |
1962114-92-6 |
詳細(xì)
|
| Erythromycin 4'- |
紅霉素4’-甲基雜質(zhì)48 |
200802-92-2 |
詳細(xì)
|
| Flomoxef Impurity 34 |
氟氧頭孢雜質(zhì)34 【需要客戶提供原料】 |
|
詳細(xì)
|
| (4AR,6R,7aS)-6-(6-amino-9H-purin-9-yl)-2-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide |
（4AR，6R，7aS）-6-（6-氨基-9H-嘌呤-9-基）-2-羥基四氫-4H-呋喃[3,2-d][1,3,2]二氧雜膦-2-氧化物 |
1157-33-1 |
詳細(xì)
|
| Flomoxef Impurity 33 |
氟氧頭孢雜質(zhì)33 【需要客戶提供原料】 |
|
詳細(xì)
|
| Brivaracetam Impurity 84 |
布瓦西坦雜質(zhì)84 |
2200297-71-6 |
詳細(xì)
|
| Ilexoside D |
冬青苷D；毛冬青皂苷B1 |
109008-27-7 |
詳細(xì)
|
| Isosorbide Impurity 21 |
硝酸異山梨酯雜質(zhì)21 |
28218-55-5 |
詳細(xì)
|
| Metronidazole Impurity 31 |
甲硝唑雜質(zhì)31 |
|
詳細(xì)
|
| Ketorolac Impurity 59 |
酮咯酸雜質(zhì)59 |
2705552-46-9 |
詳細(xì)
|
| Ketorolac Impurity 56 |
酮咯酸雜質(zhì)56 |
952569-58-3 |
詳細(xì)
|
| Flomoxef Impurity 32 |
氟氧頭孢雜質(zhì)32【需要客戶提供原料】 |
|
詳細(xì)
|
| Revefenacin Dimer Impurity 8 |
雷芬那辛二聚雜質(zhì)8 |
|
詳細(xì)
|
| Pyridine-2,5-dicarbonitrile |
吡啶-2,5-二甲腈 |
20730-07-8 |
詳細(xì)
|
| Metoclopramide Impurity 43 HCl |
甲氧氯普胺雜質(zhì)43 HCl |
22459-75-2 |
詳細(xì)
|
| Ophiopogonin A |
|
11054-24-3 |
詳細(xì)
|
| Vilanterol Impurity 54 HCI |
維蘭特羅雜質(zhì)54鹽酸鹽 |
1463889-71-5 |
詳細(xì)
|
| 1-Bromo-2,3,4,5-tetrachlorobenzene |
|
1125-52-6 |
詳細(xì)
|
| (2S-trans)-Diltiazem Hydrochloride |
|
103532-26-9 |
詳細(xì)
|
| Teneligliptin Impurity 16 |
特力利汀雜質(zhì)16 |
|
詳細(xì)
|
| Ketorolac Impurity 52 |
酮咯酸雜質(zhì)52 |
147088-89-9 |
詳細(xì)
|
| 4-(tert-Butyl)benzenesulfonic acid |
對叔丁基苯磺酸 |
1133-17-1 |
詳細(xì)
|
| Sorafenib beta-D-Glucuronide |
|
1130164-93-0 |
詳細(xì)
|
| Tropinol enantiomer impurity |
托品醇對映體雜質(zhì) |
|
詳細(xì)
|
| Ketorolac Impurity 51 |
酮咯酸雜質(zhì)51 |
111122-84-0 |
詳細(xì)
|
| Pioglitazone-d4 (major) |
|
1134163-31-7 |
詳細(xì)
|
| (±)-Hydroxybupropion-D6 |
|
1184984-06-2 |
詳細(xì)
|
| (E)-4-(((2-fluorophenyl)imino)methyl)phenol |
（E） -4-（（（2-氟苯基）亞氨基）甲基）苯酚 |
1829558-56-6 |
詳細(xì)
|
| Flomoxef Impurity 35 |
氟氧頭孢雜質(zhì)35 【需要客戶提供原料】 |
|
詳細(xì)
|
| 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylicacid 3-ethylester |
|
113994-38-0 |
詳細(xì)
|
| Ethyl 5-methylhexanoate |
|
10236-10-9 |
詳細(xì)
|
| Ozefloxacin Impurity 3 |
奧澤沙星雜質(zhì)3 |
|
詳細(xì)
|
| 4-boron-D-phenylalanine |
4-硼-D-苯丙氨酸 |
111821-49-9 |
詳細(xì)
|
| (2-(6-(Azepan-1-yl)pyridin-3-yl)pyrrolidin-1-yl)(phenyl)methanone |
(2-(6-(氮雜環(huán)庚烷-1-基)吡啶-3-基)吡咯烷-1-基)(苯基)甲酮 |
1352499-72-9 |
詳細(xì)
|
| Ketorolac Impurity 58 |
酮咯酸雜質(zhì)58 |
|
詳細(xì)
|
| A0S961SVRW
1172-63-0
Jasmolin II
Jasmolin II [BSI:ISO]
Cyclopropanecarboxylic acid, 3-(3-methoxy-2-methyl-3-oxo-1-propenyl)-2,2-dimethyl-, 2-methyl-4-oxo-3-(2-pentenyl)-2-cyclopenten-1-yl ester, (1R-(1alpha(S*(Z)),3beta(E)))-
Cyclopropanecarboxylic acid, 3-((1E)-3-methoxy-2-methyl-3-oxo-1-propenyl)-2,2-dimethyl-, (1S)-2-methyl-4-oxo-3-(2Z)-2-pentenyl-2-cyclopenten-1-yl ester, (1R,3R)-
Jasmoline II [ISO-French]
(1R-(1alpha(S*(Z)),3beta(E)))-2-Methyl-4-oxo-3-(2-pentenyl)-2-cyclopenten-1-yl 3-(3-methoxy-2-methyl-3-oxo-1-propenyl)-2,2-dimethylcyclopropanecarboxylate
Jasmoline II
UNII-A0S9 |
|
1172-63-0 |
詳細(xì)
|
| Amisulpride Impurity 11 |
氨磺必利雜質(zhì)11 |
261614-86-2 |
詳細(xì)
|
| Ketorolac Impurity 57 |
酮咯酸雜質(zhì)57 |
|
詳細(xì)
|
| Pazufloxacin lmpurity21 HCI |
帕珠沙星雜質(zhì)21鹽酸鹽 |
171567-51-4 |
詳細(xì)
|
| Ethacridine Lactate Impurity 31 |
乳酸依沙吖啶 |
36711-56-5 |
詳細(xì)
|
| 8-Benzyl 1,3-di-tert-butyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-1,3,8-tricarboxylate |
8-芐基-1,3-二-叔丁基2,4-二氧-1,3,8-三氮雜螺[4.5]癸-1,3,8-三甲酸酯 |
1005187-65-4 |
詳細(xì)
|